available for iOS, Android & web
May 31, 2011
A ban on direct-to-consumer advertising (DTCA) of new medicines during the first two years after regulatory approval could prove harmful to patients, the US Congressional Budget Office (CBO) has warned.
International Clinical Researcher of the Year 2016
Last chance to enter!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions